Results 171 to 180 of about 18,078 (213)
Some of the next articles are maybe not open access.
The Butyrylcholinesterase Knockout Mouse as a Model for Human Butyrylcholinesterase Deficiency
The Journal of Pharmacology and Experimental Therapeutics, 2008Butyrylcholinesterase (BChE) is an important enzyme for metabolism of ester drugs. Many humans have partial or complete BChE deficiency due to genetic variation. Our goal was to create a mouse model of BChE deficiency to allow testing of drug toxicity.
Bin, Li +3 more
openaire +2 more sources
A mechanistic model for butyrylcholinesterase
Biochimica et Biophysica Acta (BBA) - Enzymology, 1979A plausible mechanism of action of horse serum butyrylcholinesterase is proposed. It includes substrate activation at the level of deacylation. The rate constant for the acylation of the enzyme appears to be much greater than the rate constant for the deacylation, at low substate concentrations.
H, Eriksson, K B, Augustinsson
openaire +2 more sources
Butyrylcholinesterase formulated in liposomes
Biotechnology and Applied Biochemistry, 1999Exogenous cholinesterases have the potential to take part in defence against organophosphate toxins, by acting as scavenger systems. Postulating that formulation in liposomes could enhance the toxin‐scavenging potential of these enzymes, we have initiated studies of such formulations and are reporting here our first steps, exploring ...
I, Schumacher, A, Arad, R, Margalit
openaire +2 more sources
Butyrylcholinesterase in metabolic syndrome
Medical Hypotheses, 2010Butyrylcholinesterase may have a role in a number of metabolic functions and could affect the expression of insulin resistance syndrome. We present our integrated work using clinical, biochemical and bioinformatic approaches to delineate the possible function of this enzyme.
Gumpeny R, Sridhar +11 more
openaire +2 more sources
‘Inverse’ substrates for butyrylcholinesterase
Biochimica et Biophysica Acta (BBA) - Enzymology, 19801. 'Inverse'-type substrates for butyrylcholinesterase (acylcholine acylhydrolase, EC 3.1.1.8), i.e., p- and o-nitrophenyl esters of (3-carboxypropyl)-trimethylammonium iodide, (4-carboxybutyl)trimethylammonium iodide and (5-carboxypentyl)trimethylammonium iodide were prepared, and their kinetic parameters for butyrylcholinesterase-catalyzed hydrolysis
M, Nozawa, K, Tanizawa, Y, Kanaoka
openaire +2 more sources
Imaging Butyrylcholinesterase in Multiple Sclerosis
Molecular Imaging and Biology, 2020Molecular imaging agents targeting butyrylcholinesterase (BChE) have shown promise in other neurodegenerative disorders and may have utility in detecting changes to normal appearing white matter in multiple sclerosis (MS). BChE activity is present in white matter and localizes to activated microglia associated with MS lesions. The purpose of this study
M. W. D. Thorne +6 more
openaire +2 more sources
Butyrylcholinesterase activity in schizophrenic patients
Annales de biologie clinique, 2011Butyrylcholinesterase (BChE) is an enzyme that has been investigated for its putative role in neurodegenerative and neuropsychiatric disorders. The aim of our work was to study BChE activity variations in schizophrenic patients and to investigate the involvement of this enzyme in schizophrenia and the importance of determining its activity in this ...
Hajer, Mabrouk +6 more
openaire +2 more sources
Resveratrol Derived Butyrylcholinesterase Inhibitors
Archiv Der Pharmazie, 2013Novel polyhydroxylated (E)‐stilbenes were synthesized by Mizoroki–Heck reactions and tested for their ability to inhibit the enzymes acetyl‐ and butyrylcholinesterase. Several of them are good inhibitors of butyrylcholinesterase; one of them carrying an extra fluorine substituent is a 94‐fold stronger inhibitor of butyrylcholinesterase than of ...
René Csuk, Ralph Kluge, Dieter Ströhl
exaly +3 more sources
Butyrylcholinesterase as a Blood Biomarker in Neuroblastoma
Journal of Pediatric Hematology/Oncology, 2017Blood-based biomarkers are important in the detection of the disease and in the assessment of responses to therapy. In this study, butyrylcholinesterase was evaluated as a potential biomarker in newly diagnosed neuroblastoma (NB) patients at diagnosis and longitudinally during treatment.
Don W, Coulter +6 more
openaire +2 more sources
An improved method for butyrylcholinesterase phenotyping
Biochemical Genetics, 1994An improved method for the identification of butyrylcholinesterase phenotypes is proposed. It is based on modifications of a method that uses alpha-naphthyl acetate as substrate and DL-propranolol and Ro2-0683 as inhibitors. The proposed modifications make the method more rapid and increase the accuracy of the determinations of the phenotypes tested ...
G, Picheth +4 more
openaire +2 more sources

